Your browser doesn't support javascript.
loading
Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation.
Sousa, A R; Marshall, R P; Warnock, L C; Bolton, S; Hastie, A; Symon, F; Hargadon, B; Marshall, H; Richardson, M; Brightling, C E; Haldar, P; Milone, R; Chalk, P; Williamson, R; Panettieri, R; Knowles, R; Bleecker, E R; Wardlaw, A J.
Afiliação
  • Sousa AR; GlaxoSmithKline Stevenage, Stevenage, UK.
  • Marshall RP; GlaxoSmithKline Stevenage, Stevenage, UK.
  • Warnock LC; GlaxoSmithKline Stevenage, Stevenage, UK.
  • Bolton S; Institute for Lung Health, Department of Infection Immunity and Inflammation, University of Leicester, Respiratory Biomedical Research Unit University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Hastie A; Center for Genomics & Personalized Medicine, Section of Pulmonary & Critical Care Medicine, Wake Forest School of Medicine, Medical Center Blvd., Winston-Salem, NC, USA.
  • Symon F; Institute for Lung Health, Department of Infection Immunity and Inflammation, University of Leicester, Respiratory Biomedical Research Unit University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Hargadon B; Institute for Lung Health, Department of Infection Immunity and Inflammation, University of Leicester, Respiratory Biomedical Research Unit University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Marshall H; Institute for Lung Health, Department of Infection Immunity and Inflammation, University of Leicester, Respiratory Biomedical Research Unit University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Richardson M; Institute for Lung Health, Department of Infection Immunity and Inflammation, University of Leicester, Respiratory Biomedical Research Unit University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Brightling CE; Institute for Lung Health, Department of Infection Immunity and Inflammation, University of Leicester, Respiratory Biomedical Research Unit University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Haldar P; Institute for Lung Health, Department of Infection Immunity and Inflammation, University of Leicester, Respiratory Biomedical Research Unit University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Milone R; GlaxoSmithKline Stevenage, Stevenage, UK.
  • Chalk P; Knowles Consulting, Stevenage, UK.
  • Williamson R; GlaxoSmithKline Stevenage, Stevenage, UK.
  • Panettieri R; Rutgers, the State University of New Jersey, New Jersey, USA.
  • Knowles R; Knowles Consulting, Stevenage, UK.
  • Bleecker ER; Center for Genomics & Personalized Medicine, Section of Pulmonary & Critical Care Medicine, Wake Forest School of Medicine, Medical Center Blvd., Winston-Salem, NC, USA.
  • Wardlaw AJ; Institute for Lung Health, Department of Infection Immunity and Inflammation, University of Leicester, Respiratory Biomedical Research Unit University Hospitals of Leicester NHS Trust, Leicester, UK.
Clin Exp Allergy ; 47(7): 890-899, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28493293
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Prednisolona / Antiasmáticos / Eosinófilos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Prednisolona / Antiasmáticos / Eosinófilos Idioma: En Ano de publicação: 2017 Tipo de documento: Article